bluetongue disease | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

90,397 results for “bluetongue disease”

EMA Recommends Approval of Bluevac-3 and Syvazul BTV 3 Vaccines for Bluetongue Disease

Boehringer Ingelheim Achieves Significant Pipeline Progress in First Half of 2024

New Alzheimer's Treatments Slow Disease Progression, Offer Hope for Early-Stage Patients

Boehringer Ingelheim Prepares for Multiple New Product Launches in 2025 Following Strong R&D Investment

FDA Approves Zanvastro, First Disease-Modifying Therapy for Alexander Disease

Parkinson's Disease Research Focuses on Disease-Modifying Therapies

Golexanolone Shows Promise as Early Disease-Modifying Treatment for Parkinson's Disease

Early Disease Screening Programs Show Significant Impact on Chronic Disease Prevention

Gildeuretinol Receives FDA Fast Track and Rare Pediatric Disease Designations for Stargardt Disease

Advances in Alzheimer's Disease Treatment: A Focus on Disease-Modifying Therapies

Page 1 of 2107